ESC 365 - Early sudden cardiac death risk in newly diagnosed HFrEF patients – how to manage early guideline recommended medical therapy up-titration and the role of the wearable cardioverter defibrillator?

EHRA Premium Access

Early sudden cardiac death risk in newly diagnosed HFrEF patients – how to manage early guideline recommended medical therapy up-titration and the role of the wearable cardioverter defibrillator?

Session: Early sudden cardiac death risk in newly diagnosed HFrEF patients – how to manage early guideline recommended medical therapy up-titration and the role of the wearable cardioverter defibrillator?

Topic: Wearable Defibrillator (WCD)

Speaker: Professor A. Breitenstein (Zurich, CH) Professor D. Duncker (Hannover, DE)

Sponsored by ZOLL Cardiac Management Solutions

Event: EHRA 2024

Congress Presentation

Add to my library

About the speakers

Professor Alexander Breitenstein

University Heart Center, Zurich (Switzerland)

29 presentations

3 followers

Professor David Duncker

Hannover Heart Rhythm Center, Hannover (Germany)

26 presentations

19 followers

Access the full session

Early sudden cardiac death risk in newly diagnosed HFrEF patients – how to manage early guideline recommended medical therapy up-titration and the role of the wearable cardioverter defibrillator?

Speakers: Professor A. Breitenstein, Professor D. Duncker

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources